All entries for: Charles River Laboratories International

February 18, 2026

Charles River Laboratories International

Negative Outlook

Netherlands
10,001-50,000 employees

The IRA is anticipated to have significant effects on the pharmaceutical industry and may reduce the prices we can charge and reimbursement we can receive for our products, among other effects.

Disease Area: Immune Diseases, Infectious Diseases, Neurological Diseases, Oncology, Rare Disease, Respiratory Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top